Chest Mobility, Strength, Physical Activity and Quality of Life in Parkinson's Patients With Post-COVID-19

Parkinson Disease Clinical Trial

Official title: Chest Mobility, Cough Strength, Muscle Strength, Physical Activity and Quality of Life in Parkinson's Patients Who Have Had COVID-19

Status Recruiting

Clinical Trial Summary

To comparative pain intensity, chest mobility, cough strength, muscle strength, physical activity levels and quality of life in Parkinson's patients with post-COVID-19 and without post-COVID-19 was aimed in current study. Knowledge in the literature regarding this topic is still obscure.

Clinical Trial Description

Acute worsening and long-term sequelae of motor and non-motor symptoms have also been described in Parkinson's patients during and after SARS-CoV-2 infection, which is also known as prolonged COVID. The effects of COVID-19 on pain, chest mobility, cough strength, muscle strength, physical activity levels and quality of life in Parkinson's patients are still unclear today. For this reason, in this study, it was aimed to comparatively investigate pain, chest mobility, cough strength, muscle strength, physical activity levels and quality of life in Parkinson's patients with COVID-19 and without COVID-19 and to show the relationships between these outcome measures. ;

Related Conditions & MeSH terms

• COVID-19
• Parkinson Disease
• Respiratory Tract Infections

• NCT number: NCT06008444
• Study type: Observational [Patient Registry]
• Source: Izmir Democracy University
• Contact: GÜLSAH BARGI
• Phone: +90 232 299 0739
• Email: gulsahbargi35@gmail.com
• Status: Recruiting
• Start date: May 13, 2023
• Completion date: December 2024